A Study of Immune Response to Hepatitis B Vaccine & HBV DNA in Isolated Anti-HBc Positive Subjects
![]() |
Kim, Soon-Duck
(Department of Preventive Medicine, College of Medicine, Korea University)
Choi, Ji-Ho (Department of Family medicine, College of Medicine, Inha University) Kim, Sung-Ryul (Department of Family medicine, College of Medicine, Inha University) Lee, Jin-Soo (Department of Infectious internal medicine, College of Medicine, Inha University) Koh, Hee-Jeong (Department of Family medicine, College of Medicine, Inha University) |
1 | Bart PA, Jacquier P, Zuber PLF, Lavanchy D, Frei PC. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006. women at delivery Liver 1996; 16: 110-116 |
2 | Hu M, Schenzle D, Deinhardt F, Scheid R. Epidemiology of hepatitis A and B in the shanghai area: prevalence of serum markers, Am J Epidemiol; J 1984; 120: 404-413 PUBMED |
3 | Davidson M, Krugman S. Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose. J Infect 1986: 13: 31-38 PUBMED |
4 | Chan CY, Lee SD, Tsai YT. Lo KJ. Hepatitis H vaccination alone IS not adequate for the categolizing of adult subjects with isolated anti-HBc. J Gastroenterol Hepatol 1995: 10: 192-197 DOI ScienceOn |
5 | The annual report of health promotion center, Aasan Medical Center. the seventh edition, 2003 |
6 | Feret E, Larauze B, Diop E, Sow M, London WT, Blumberg BS, Epidemiology of hepatitis B virus infection in the rural community of tip. Senegal Am J Epidemiol 1987; 125 :140-149 |
7 | Ural O, Findik D. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine. J Infect 2001;43: 187-190 DOI ScienceOn |
8 | Kara IH, Yilmaz ME, Suner A, Kadiroglu AK. lsikoglu B, The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients, Vaccine 2004 28(22); 22: 3963-3967 |
9 | Lok ASF, Lai CL, Wu PC: Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: Implication in hepatitis B vaccination programs. Hepatology 1988;8:766-770 DOI PUBMED |
10 | Hofer M, Joller-Jemelka HI, Grab PJ, Luthy R, Opravil M, Frequent chronic hepatitis 13 virus infection in HIV infected patient, positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 1998: 17: 6-13 DOI ScienceOn |
11 | Chan HY, Lok AF. Hepatitis B in adults: A clinical perspective. Clin Liver Dis 1999; 3: 291-307 DOI ScienceOn |
12 | General recommendations of vaccination. Ministry of Health and Welfare, Advisory Committee on Vaccination 1998 |
13 | Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms LT, Solomon LR. Barbosa LH, Nemo GJ. Donor screenig for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995: 35: 5-12 DOI ScienceOn |
14 | Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med 1989; 87: 14S-20S |
15 | Deinhardt F. Serum markers of hepatitis B viruses in natural disease and after vaccination. Prog Liver Dis 1982; 7: 451-467 PUBMED |
16 | Oh MK, Kim JS, Lee YB, Han JH. Seroprevalence of hepatitis B virus markers among adult in a Yungdong area of Kwangwon province. J Korean Acad Fam Med 2000; 21(1): 91-99 (Korean) |
17 | Silva AE, McMahon BJ, Parkinson AJ, Sjogren MH, Hoofnagle JH, Di Bisceglie AM. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine, Clin Infect Dis 1995; 26:8 95-97 DOI ScienceOn |
18 | Ljunggren KK, Norbengelt E, Kidd A Correlation of HBeAg/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive patients, J Med Virol 1993: 39(4): 297-302 DOI ScienceOn |
19 | Sunbul M, Leblebicioglu H, Esen S, Eroglu C, Barut S. Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects Scand. J lnfect Dis 2000; 32: 315-316 |
20 | B. Duval, N. Boulianne, G. De Serres. P, De Walis P, Masse R, Trudeau G, Delage G, Desjardins L, Salary A. Should children with isolated anti-HBs or ani-HBc be immunized against hepatitis B virus? JAMA 1997; 278: 1064 |
21 | Zuckerman JN, Zuckerman AJ. Current topics in hepatitis B. J Infect 2000; 41: 130-6 DOI ScienceOn |
22 | Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, Zetterman RK, Pruett TL, lshitani MB, Hoofnagle JH. Transmission of hepatitis B by transplantstion of livers from donors positive for antibody to hepatitis B core antigen. The national institute of diabetes and digestive and kidney diseases liver transplantation database. Gastroenterology 1997: 113: 1668-1674 DOI PUBMED ScienceOn |
23 | Draelos M. Morgan T, Schifman RB, Sampliner RE. Signiticance of isolated antibody to hepatitis B core antigen determined by immune response to hepatitis B vaccinatlon. JAMA 1987; 258(9): 1193-1195 DOI ScienceOn |
24 | Brechot C, Dcgos F, Lugassy C, Thiers V, Zafrani S, Franco D, Bismuth H, Trepo C, Benhamou JP, Wands J, Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen, N Engl J Med 1985; 31: 270-276 |
25 | Lai CL, Lau JYN, Yeoh EK, Chang WK, Lin HJ. Significance of isolated anti-HBc sempositivity by ELISA: Implications and the role of radioimmunoassay. J Med Virol 1992: 36: 180-183 DOI ScienceOn |
26 | Rumi M, Colombo M, Romeo A. Boschini A. Zanetti A. Gringeri A, Mannucci PM, Suboptimal response to hepatitis B vaccine in drug users, Arch. lntern Med 1991: 151: 574-578 DOI ScienceOn |
27 | Grob P, Jilg W, Bomhak H, Gerken G, Gerken G, Gerlich W, Gunther S, Hess G, Hudig H. Kitchen A, Margolis H, Michel G, Trepo C, Will H, Zanetti A, Mushahwar I. Serological pattern 'Anti-HBc Alone': Report on a workshop. J Med Virol. 2000; 62(4): 450-455 |
28 | Yoo K, Lee HS, Kim CY. Detection of HBV DNA in patients with chronic liver disease with Isolated antibody to HBcAg using the polymerase chain reaction. Korean J Gastroenterol 1991; 23: 469-474 (Korean) |
29 | Parkinson AJ, McMahon BJ, Hall D, Ritter D, Fitzgerald MA. Comparison of enzyme imnunoassay with radioimnunoassay tor the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B. J Med Virol 1990; 30: 253-257 DOI ScienceOn |
30 | McMahon BJ, Parkinson AJ, Helminiak C, Wainwright RB, Bulkow L, Kellerman-Douglas A, Schoenberg S. Ritter D. Response to hepatitis B vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103(2): 590-594 PUBMED |
31 | Wu JS, Chen CH, Chiang YH, Lee YC, Lee MH, Ko YC, Hu HT. Hepatitis B virus infection in Taiwan with reference 10 anti-HBc versus HBsAg and anti-HBs. J Formosan Med Assoc 1980: 79: 760-767 |
32 | Douglas DD, Taswell HF', Rakela J, Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993; 33: 212-216 DOI ScienceOn |
33 | McMahon BJ, Bender TR, Berquist KR. Schreeder MT, Harpster AP. Delayed development of antibody to hepatitis B surtace antigen after symptomatic infection with hepatitis B virus, J Clin Microhiol 1981 14: 130-134 |
34 | Khalid A. Al-Mekhaizeem, Michael Miriello and Averell H, Sherker. The frequency and significance of isolated hepatitis B core antibody and the suggested management of patients, Can Med Assoc J 2001; 165: 1063-1064 |
35 | Yoo KY, Park BJ, Ahn YO. Seroepidemiology of Hepatitis B Virus Infection in healthy Korean adults in Seoul. Korean J Prev Med 1988 21; 1:89-98(Korean) |
![]() |